Disrupting the $30bn pain management industry


Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

During 15 years in the healthcare industry, Stacy Cason was a first-hand witness to the devastating effects of chronic pain and opioid abuse. Long fascinated by the phenomenal benefits of plant medicine, she followed her passion and made it her mission to create a healthy, high-quality pain management alternative.

Cason founded Planetarie in 2018. Following extensive research and development, Planetarie created a proprietary water-extraction technology that leaves full-spectrum cannabinoids in their most potent, natural state.

The U.S. has a problem with pain relief.

Over-the-counter non-steroidal anti-inflammatories like ibuprofen often come with side effects that impact the stomach and kidneys.

Prescription opioids are even more hazardous. The U.S. consumes 80% of the world’s opioids, though its home to just over 4% of the population. This epidemic has been responsible for the deaths of more than one million Americans in the last 20 years.

CBDa, a natural selective COX-2 inhibitor, offers a healthier alternative to common painkillers. However, conventional extraction methods — using ethanol and showing remarkably few changes since the 11th century — cannot access this potent, natural pain reliever.

Planetarie developed a proprietary water extraction method, creating a breakthrough in hemp processing.

Our industry-redefining technology extracts cannabinoids in the same raw, natural form in which they grow in the hemp plant, producing a more potent, bioavailable, full-spectrum ingredient for healthier, cleaner, safer and more sustainable products.

Traditionally processed CBD uses and contains harsh chemicals and creates waste products. Planetarie’s environmentally-friendly process uses no harsh chemicals or additives, preserving the raw form of CBDa.

CBDa acts as a selective COX-2 inhibitor, making it a safe and effective alternative to NSAIDs for both chronic and acute pain management and inflammation for elite athletes, weekend warriors or the average person.

CBDa features significant advantages over CBD:

  • Up to 1000 times more potent
  • •Scientifically proven up to 18 times more bioavailable
  • < 0.3% THC levels
  • Perfectly stable extract for years

What’s behind Planetarie’s industry-disrupting process? We can’t reveal all of our secrets, but here’s a big part of what makes us — and our products — so different:

We start with only the finest plants. Planetarie begins with Colorado-grown, USDA-certified organic hemp, not a commodity imported from China lacking a chain of custody or lab testing.

Our process is a trade secret. We perform our water magic with our USDA organic-certified process and facility.

Our products have a stable base. We create products with CBDa. CBDa, the acidic precursor to CBD, is a natural, potent anti-inflammatory. Before Planetarie, CBDa was difficult to obtain in a stable form. We made it easy.

We go vertical. Planetarie is vertically integrated. We manage every step of the process, ensuring the highest quality of our custom, in-house formulated, end-consumer products. 

Product development | We’ve had products in market for two-plus years and currently have 17 individual SKUs. Future products include capsules, gummies, chocolates and bath salts.

Customer acceptance | We’ve sold over 10,000 products in the B2C space. Our return customer rate tops 70% and nearly all of our reviews hit 5 stars. Our flagship products include soft gels, tinctures and topical muscle cream.

Social proof | Notable fans of our products include Mikhail Kogan, MD and other top physicians in the space, pro triathletes and Olympian Carmichael.

Impressive partners | We have partnerships with Carmichael Training Systems, NFL Alumni Association, Realm of Caring, Hope Grows for Autism, Dr. Mikhail Kogan, Real Tri Squad and 1% for the Planet.

Media mentions | Planetarie has garnered attention from outlets including Forbes, NBC, Better Nutrition, Denver Business Journal, Portland Business Journal, ABC, FOX, Business Insider and American Spa.

Research project secured | We are launching a major research project with Louisiana State University to prove the anti-inflammatory properties of CBDa.

Grant| We have applied for a grant through the National Institute of Health for federal funding. 

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.

Request Access


No updates yet.


No backers yet.

Quick Signup TBD

You must have an account to do this!

the platform

Copyright © 2019 All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.